FIELD: chemistry.
SUBSTANCE: present invention relates to complex iron compound (III). Compound contains at least one ligand of formula (I): , where arrows denote coordination connection with one or different iron atoms, R1 is selected from group consisting of linear or branched C1-8-alkyl, which can be substituted with C1-6-alkoxy (RO-), where R denotes unsubstituted alkyl, or C1-8-alkoxycarbonyl (RO-CO-), where R denotes unsubstituted alkyl; R2 is selected from group consisting of hydrogen atom, unsubstituted C1-8-alkyl, halogen atoms and cyano group, or R1 and R2, together with carbon atoms with which they are bonded form unsubstituted 5- or 6-member ring, R3 and R4 are respectively selected from group consisting of hydrogen atoms, morpholinyl, C3-6-cycloalkyl and linear or branched C1-8-alkyl which can be substituted with hydroxy, alkoxy, cycloalkyl, C1-8-alkoxycarbonyl (RO-CO-), where R denotes unsubstituted alkyl, or R3 and R4, together with nitrogen atom with which they are bonded form optionally substituted 3-6-member ring which optionally can contain one or more additional heteroatoms selected from N and O, or its pharmaceutically acceptable salts. Also disclosed is use of complex compounds and pharmaceutical composition.
EFFECT: obtained compounds are intended for use as therapeutic agents for treating and/or preventing symptoms of iron deficiency and iron-deficiency anaemia.
16 cl, 1 tbl, 80 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEX COMPOUNDS OF FERRIC IRON FOR TREATMENT AND PREVENTION OF SYMPTOMS OF IRON DEFICIENCY AND IRON DEFICIENCY ANEMIA | 2013 |
|
RU2641030C2 |
METHOD FOR PREPARING 2-(AZOL-1-YL)ETHANEAMINES | 2006 |
|
RU2317984C2 |
METHOD OF OBTAINING SGLT2 BENZYLENBENZOLE INHIBITORS | 2013 |
|
RU2625795C2 |
BENZOXAZOLONE DERIVATIVES SHOWING ANTIINFLAMMATORY ACTIVITY | 1991 |
|
RU2024512C1 |
LIGAND AND COMPLEX FOR CATALYTIC WHITENING SUBSTRATE | 2001 |
|
RU2283342C2 |
DERIVATIVES OF CYCLOPENTANE- OR CYCLOPENTENE--β--AMINO ACIDS AND THEIR SALTS, A COMPOSITION EXHIBITING ACTIVITY WITH RESPECT TO THE STRAINS STREPTOCOCCUS AUREUS, CANDIDA AND TRICHOPHYTON | 1993 |
|
RU2126379C1 |
CAMPTOTHECIN ANALOGS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2190613C2 |
5-ARYL-1H-1,2,4-TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | 2000 |
|
RU2249588C2 |
CARBOXYLIC ACID DERIVATIVES | 1995 |
|
RU2180335C2 |
2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AND 2-(4- HYDROXYPIPERIDINO)-1-ALKANONE DERIVATIVES | 1992 |
|
RU2065859C1 |
Authors
Dates
2016-07-10—Published
2011-03-22—Filed